Orally administered sutezolid is rapidly oxidized in vivo to an active sulfoxide metabolite (PNU-101603), which then undergoes renal excretion.
Products > Drug Discovery > Inhibitor > Other Inhibitors | Products > Drug Discovery > Inhibitor
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。